The isothermal nucleic acid amplification technology (INAAT) market is segmented into assay, kits, reagents, and systems, with the LAMP segment accounting for the largest share of the market. The largest application segment of the market is infectious disease diagnosis, while hospitals account for the largest share of the end-user market. North America leads the market, followed by Europe. The key market players include Hologic, Abbott Laboratories, Becton, Dickinson and Company, and Tecan Trading AG. Recent developments include new molecular assays from Hologic and a rapid COVID-19 testing device approval in Canada from Abbott. The new edition of the report provides an updated product portfolio of the companies profiled in the report, as well as competitive leadership mapping for INAAT vendors. The report includes market strategies, market share analysis, revenue share analysis, and competitive leadership mapping in the competitive landscape section.
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market is expected to grow significantly in the near future, thanks to increasing government initiatives, rising prevalence of infectious diseases, and technological advancements in the field. INAAT is a revolutionary, rapid, and cost-effective technology used for amplifying and detecting nucleic acid targets. It is being used in a variety of applications such as diagnostic testing, food safety, and environmental monitoring. The INAAT market is projected to reach $6.8 billion by 2028, growing at a CAGR of 9.2% from 2023 to 2028. The market was estimated to be worth $4.4 billion in 2023. Prominent players operating in the INAAT market include Grifols, S.A., Hologic, Inc., Abbott Laboratories, Becton, Dickinson and Company, Meridian Bioscience, Eiken Chemical Co., Ltd., bioMérieux SA, and Tecan Trading AG.
The assay, kits, and reagents segment accounted for the largest share of the INAAT market. The growth of the market is attributed to growing funding initiatives for molecular diagnostics and infectious diseases, and recent launches of INAAT consumables by prominent market players. However, the unfavorable reimbursement scenario for in vitro diagnostic tests is a major factor restraining market growth.
MarketsandMarkets™ has published an illustrative overview and an in-depth table of contents (TOC) for the Isothermal Nucleic Acid Amplification Technology Market, which contains 226 tables, 46 figures, and 235 pages.
The isothermal nucleic acid amplification technology (INAAT) market is segmented based on product, technology, application, end user, and region. The assay, kits, and reagents segment accounted for the largest share of the INAAT market in 2022. The loop-mediated isothermal amplification (LAMP) segment dominated the market in 2022 due to the prominent players in the market offering LAMP kits and the increasing use of LAMP kits in infectious disease diagnostics. The infectious disease diagnosis segment is expected to dominate the market in 2022, owing to the launch of INAAT Covid-19 kits and the extensive use of INAAT in the diagnosis of Hepatitis and HIV. The hospital segment is expected to account for the largest share of the INAAT market in 2022, due to the high demand for fast tests and kits, an increase in the patient population, and the extensive use of molecular diagnostic kits.
North America is expected to account for the largest share of the global INAAT market, followed by Europe in 2022. The largest share of the North American market is attributed to the presence of leading market players, growing burden of infectious diseases, and availability of R&D funding for molecular diagnostics. The growth of the market is attributed to recent launches of INAAT consumables by prominent market players, growing funding initiatives for molecular diagnostics and infectious disease diagnostics, and a high prevalence of infectious diseases. The unfavorable reimbursement scenario for in vitro diagnostic tests is a major factor restraining market growth.
MarketsandMarkets™ has published a free sample page for an overview of the Isothermal Nucleic Acid Amplification Technology Market Dynamics. The report highlights the opportunities for the market, such as advancements in INAAT technology and rising demand for INAAT products in emerging countries.
The isothermal nucleic acid amplification technology (INAAT) market is witnessing significant growth, with many start-ups focusing on INAAT and prominent market players operating in the industry. INAAT tests are being used as point-of-care tools due to their rapid, cost-effective, and reliable nature. The market is projected to witness remarkable growth in the near future due to increasing government initiatives in the field of diagnostics, the rising prevalence of infectious diseases, and technological advancements.
Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), and many others are the prominent players operating in the INAAT market. These players offer a wide range of INAAT products and have been introducing new molecular assays and systems in the market.
Recent developments in the INAAT market include Hologic, Inc. (US) receiving CE marking for two new molecular assays, Panther Fusion EBV Quant Assay and Panther Fusion BKV Quant Assay, in May 2022. In December 2021, Hologic, Inc. (US) launched Panther Trax, which offers full automation to meet high-volume testing demands. Abbott (US) received approval from Health Canada for the ID NOW rapid COVID-19 testing device for use in Canada in September 2020.
The new edition of the isothermal nucleic acid amplification technology market report provides an updated financial information till 2022 for each listed company in a graphical representation, helping to analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus. The report also includes additional points, such as trends/disruptions impacting customers’ businesses, pricing analysis, value chain analysis, ecosystem analysis, regulatory landscape, Porter’s five forces analysis, key conferences & events in 2023-2024, technology analysis, key stakeholders and buying criteria, and patent analysis, to provide a comprehensive overview of the market.
The report includes an updated product portfolio of the 25 companies profiled. The competitive landscape section has been enhanced with market share and revenue share analysis for 2022 and competitive leadership mapping. The mapping evaluates the top 25 vendors based on market shares/rankings and product footprint. For media inquiries, contact MarketsandMarkets™ Research Private Ltd. at their Northbrook, Illinois address or visit their website for more information on the isothermal nucleic acid amplification technology market.
Don’t miss interesting posts on Famousbio
